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Abstract
Background: Activation of microglia can result in phenotypic and functional diversity. However, the pathways that
trigger different states of microglial activation remain to be fully understood. Here, we hypothesized that after injury,
astrocytes and endothelium may contribute to a gliovascular switch for microglial activation.
Methods: Astrocytes or cerebral endothelial cells were subjected to oxygen glucose deprivation, then conditioned
media were transferred to microglia. The release of TNFα, IL-1β, IL-10, and IGF-1 was measured using ELISA. Surface
markers of CD11b, CD45, CD86, and MHC class II were detected by flow cytometry. mRNA expression of iNOS, CD86,
CD206, Arginase1, and transcription factors was measured using real-time PCR. Microglial function including migration
and phagocytosis was assessed. Dendritogenesis was determined by counting the number of primary dendrites,
secondary dendrites, and dendritic ends in the neurons exposed to either endothelial- or astrocyte-activated microglia.
Results: Exposure to conditioned media from oxygen-glucose-deprived cerebral endothelial cells or oxygen-glucose-
deprived astrocytes activated microglia into different forms. The endothelium converted ramified microglia
into amoeboid shapes; increased the release of TNFα, IL-1β, and IL-10; decreased IGF-1; upregulated iNOS
expression; and inhibited microglial migration and phagocytosis. In contrast, astrocytes increased microglial
production of IGF-1, upregulated CD206 expression, and enhanced microglial phagocytosis. These opposing
effects of the endothelium versus astrocyte crosstalk partly mirror potentially deleterious versus potentially
beneficial microglial phenotypes. Consistent with this idea, endothelial-activated microglia were neurotoxic,
whereas astrocyte-activated microglia did not affect neuronal viability but instead promoted neuronal dendritogenesis.
Conclusion: These findings provide proof of concept that endothelial cells and astrocytes provide differing signals to
microglia that influence their activation states and suggest that a gliovascular switch may be involved in the balance
between beneficial versus deleterious microglial properties.
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Background
Microglia are sentinels of the brain. They constantly moni-
tor the microenvironment and actively respond to injury
and disease [1–4]. Any insult to the central nervous system
(CNS), including infection, trauma, or metabolic dysfunc-
tion, causes microglial activation. Activation of microglia
can result in phenotypic and functional diversity—harmful
or beneficial—depending on the activating conditions.
Traditionally, “M1-like” microglia are thought to be
damaging by releasing free radicals and cytokines that
amplify inflammation and secondary neuronal death [5–
7]. However, beneficial “M2-like” microglia may also exist
that promote CNS recovery by secreting neurotrophic fac-
tors [8, 9], promoting synaptic plasticity [10], and support-
ing remyelination [11] and angiogenesis [12]. Activated
microglia play a dual role in ischemic stroke. Activated
microglia can be neurotoxic by releasing reactive oxygen
species and pro-inflammatory cytokines [13–17]. On the
other hand, the accumulation of microglia may correlate
with the reduction of neuronal damage under some condi-
tions [18–21]. The neurotoxic and neuroprotective sub-
populations of microglia coordinate the inflammatory
process, and the predominance of one or the other would
result in either more damage or attempted recovery [22].
These potentially biphasic and overlapping properties of
microglia are well accepted, but the complex mechanisms
that trigger and regulate these different states of activation
remain to be fully dissected [23, 24].
The concept of the neurovascular unit suggests that in-
teractions between all cell types in the CNS mediate the
pathophysiology of stroke, brain injury, and neurodegenera-
tion [25]. More recently, the concept of help-me signaling
suggests that the balance between injury and repair in the
CNS may be mediated in part by crosstalk between mul-
tiple cells of the neurovascular unit [26–28]. Is it possible
that different states of microglial activation may also de-
pend on signaling from other CNS cell types? In the con-
text of stroke, two candidate “partners” for microglial
crosstalk and activation might comprise the endothelium
and astrocyte, because these cells respond quickly and pro-
foundly to cerebral ischemia [29, 30]. Here, we propose a
gliovascular mechanism that regulates the microglial
switch, i.e., differential signaling from reactive endothelium
or reactive astrocytes triggers different states of microglial
activation that may in turn influence neuronal viability.
Methods
Microglia
Primary microglia cultures were prepared from the cere-
bral cortices of 1-day-old neonatal Sprague-Dawley rats ac-
cording to the previously described standard methods [31,
32]. After removing the meninges, cortical tissues were
digested with 0.25% trypsin-EDTA for 30 min at 37 °C,
followed by mechanical triturating in DMEM/F12 with
10% fetal bovine serum (FBS). The mixed cortical cells
were plated in DMEM/F12 with 10% FBS, and the medium
was completely replaced every 3–4 days and confluency
was achieved after about 14 days in vitro (DIV). After then,
the microglia were isolated from mixed glial cultures via
mild trypsinization. Incubation of mixed glial cultures with
a trypsin solution (0.25% trypsin-EDTA diluted 1:4 in
DMEM/F12) for 15–25 min resulted in the detachment of
an intact layer of cells in one piece, whereas microglial cells
remained attached to the bottom of the well. Microglia
were allowed to rest overnight prior to treatments. Micro-
glia were treated with conditioned media from astrocytes
or endothelial cells for various times.
Astrocytes
Primary astrocyte cultures were prepared from the cere-
bral cortices of 1-day-old neonatal Sprague-Dawley rats
using standard methods, as previously described [33].
Briefly, the dissociated cortical cells were suspended in
DMEM containing 10% FBS and plated in 75-cm2 flasks.
After 10–14 DIV, astrocytes were obtained from the
mixed glial cultures by shaking at 220 rpm overnight to
remove microglia and oligodendrocytes. Astrocytes were
dissociated by trypsinization and then reseeded on
collagen-coated plates. Passages 2 to 4 of primary
cultured astrocytes were used for experiments.
Cerebral endothelial cells
RBE.4 cells, a rat brain endothelial cell line, were cul-
tured in flasks coated with rat tail collagen I (Corning,
Bedford, MA) and maintained in endothelial basal
medium-2 (Lonza, Hopkinton, MA) supplemented with
FBS, fibroblast growth factor-2, epidermal endothelial
growth factor, hydrocortisone, insulin-like growth factor,
ascorbic acid, VEGF, and amphotericin B.
Neurons
Primary hippocampal neuron cultures were prepared using
standard methods, as previously described [34]. Briefly, the
hippocampus was dissected out from the embryonic
Sprague-Dawley rat fetuses E19, then dissociated, both
enzymatically (0.25% trypsin-EDTA) for 15 min at 37 °C
and mechanically. The single-cell suspension was diluted
in serum-free neurobasal medium containing 2% B27
supplement and 0.5 mM L-glutamine and then seeded
onto pre-coated plates with poly-D-lysine at 3 × 105
cells/ml. The medium was half renewal every 3 days.
Neuronal cultures were used for experiments on 8–
10 days after seeding.
Oxygen-glucose deprivation
Oxygen-glucose deprivation (OGD) experiments were
performed using a humidified incubator chamber kept at
37 °C, which contained an anaerobic gas mixture (90%
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nitrogen, 5% hydrogen, and 5% carbon dioxide). To initi-
ate OGD, the culture medium was replaced with no
glucose DMEM. After OGD, the cultures were removed
from the anaerobic chamber, and the medium was
replaced with DMEM/F12 with 10% FBS in a regular in-
cubator. Astrocytes or RBE.4 cells were subjected to
OGD for 4 h, and conditioned media from astrocytes or
RBE.4 cells were collected 24 h after reoxygenation.
ELISA
Microglia were treated with endo-CM or astro-CM for
24 h, and then the releases of TNFα, IL-1β, IL-10, and IGF-
1 from endo-CM-activated microglia versus astro-CM-
activated microglia were measured. TNFα (eBioscience, San
Diego, CA), IL-1β (R&D), IL-10 (eBioscience), and IGF-1
(R&D) in cell culture supernatant were measured using
ELISA kits, according to manufacturer’s instructions.
Flow cytometry
Microglial cells were treated with the conditional media
from OGD-treated endothelial cells or astrocytes for
24 h. Cells were stained with fluorochrome-conjugated
antibodies recognizing cell surface antigens, including
CD11b, CD45, CD86, and MHC class II at 4 °C for
30 min. The expression levels of these markers were
detected by flow cytometer.
Real-time PCR
Total RNAs were extracted from cultured microglial
cells treated with conditioned media from OGD-treated
endothelial cells or astrocytes for various times. For the
analysis of mRNA expression of iNOS, CD86, CD206,
Arginase1, IRF4, IRF5, IRF7, IRF8, IRF9, STAT1, STAT3,
and STAT6, real-time PCR was carried out using
TaqMan gene expression assays (Applied Biosystems,
Carlsbad, CA), and relative expression was calculated using
the 2−ΔΔCt method with normalization to hypoxanthine
phosphoribosyltransferase 1 and β-2-microglobulin. All
real-time PCRs were performed in triplicates.
Microglia function
Cell migration assay kit (Chemicon, Billerica, MA) was
used to analyze microglial migration. Microglia suspension
was loaded into the culture well inserts (membrane pore
size of 5 μm) and placed in 24-well plates containing
serum-free DMEM/F12 media in the presence or absence
of the conditional media from OGD-treated endothelial
cells or astrocytes. After incubating for 4 h, the migrated
cells were detached from the bottom of the insert and lysed
and stained using the CyQUANT® GR Dye. The samples
were read using a fluorescence microplate reader set up at
480 nm excitation and 520 nm emission. Migrated cell
number was determined by running a fluorescent cell dose
curve. To assess phagocytosis, microglial cells were seeded
to a 96-well plate at a concentration of 1.0 × 105 cells/well
and incubated with or without the conditional media from
OGD-treated endothelial cells or astrocytes for 24 h. Then,
the cells were incubated with fluorescein-labeled Escheri-
chia coli K-12 BioParticles (Invitrogen, Grand Island, NY)
for 2 h at 37 °C. Cells were rinsed with 0.25 mg/ml trypan
blue to quench extracellular fluorescence. Intracellular
fluorescence was read using a fluorescence microplate
reader set up with excitation at 480 nm and emission
at 520 nm. The experiments were performed with five
replicates per condition and repeated a minimum of
three times.
Dendritogenesis
At 8 DIV, the hippocampal neurons were transfected
with pEGFP-C1 vector. Then, conditioned media from
OGD-treated astrocytes (astro-CM) or astro-CM-treated
microglia (astro-CM-treated MCM) were added to the
neuron cultures for 5 days. The photos of transfected
neurons were taken using Nikon microscope, and the
number of primary dendrites, secondary dendrites, and
dendritic ends was counted. The complexity of dendritic
arbors was calculated with dendritic ends divided by
primary dendrites.
Statistical analysis
Data were expressed as mean ± SD or SEM. Three to five
separate experiments were performed for measurements.
Data were analyzed using one-way ANOVA (SPSS 21) or
t test. Statistical significance was set at p < 0.05.
Results
Different effects of oxygen-glucose-deprived endothelium
versus astrocytes on microglial activation
Rat cerebral endothelial cells and astrocytes were subjected
to oxygen-glucose deprivation (OGD) for 4 h followed by
24 h of reoxygenation. As expected, endothelial cells and
astrocytes were relatively resistant to OGD, and cell viability
was not significantly affected (Additional file 1: Figure S1).
Then, we transferred OGD-injured endothelial-conditioned
media (endo-CM) and OGD-injured astrocyte-conditioned
media (astro-CM) onto the microglia to assess the overall
hypothesis that was after brain injury, endothelium and
astrocytes can shift microglial activation in different ways.
First, we observed the microglial morphology under the
different treatment conditions. Untreated “resting” micro-
glia displayed a ramified morphology (Fig. 1a, left). Endo-
CM treatment activated microglia into an amoeboid
appearance (Fig. 1a, middle). Astro-CM treatment led to
microglial cell body enlargement and reduced peripheral
branching (Fig. 1a, right).
Second, we asked whether these differentially activated
microglia show differences in representative cytokines
and growth factors. ELISAs were used to quantify the
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release of TNFα, IL-1β, IL-10, and IGF-1 from endo-CM-
activated microglia versus astro-CM-activated microglia.
The production of TNFα, IL-1β, and IL-10 were signifi-
cantly increased in endothelial-activated microglia (Fig.
1b). In contrast, TNFα, IL-1β, and IL-10 were not altered
in astrocyte-activated microglia (Fig. 1b). Opposite
responses were noted for IGF-1. Endothelial-activated
microglia showed a reduction in the IGF-1 release,
whereas astrocyte-activated microglia showed an increase
in the IGF-1 release (Fig. 1b). Because we used media
transfer, it is important to exclude the possibility that
these changes indirectly came from endothelial or astro-
cyte media, instead of directly reflecting microglial
responses. Levels of TNFα, IL-1β, IL-10, and IGF-1 in
culture media from OGD-treated endothelial cells or as-
trocytes were measured using ELISA. All the selected cy-
tokines and growth factors were either undetectable or
considerably lower (Additional file 2: Figure S2).
Third, we used flow cytometry to assess the representa-
tive cell surface antigens that may reflect different states of
microglial activation. Expression levels of CD45, CD86, and
MHC II were significantly elevated in endo-CM-treated
microglia (Fig. 2a). In contrast, no changes in these cell sur-
face markers were detected in astro-CM-treated microglia
(Fig. 2a). Neither endothelial- nor astrocyte-activated
microglia showed any response in CD11b (Fig. 2a).
Fourth, we used real-time PCR to further characterize
different markers of microglia activation. Both endo-CM
and astro-CM treatments significantly increased the
microglial expression of iNOS, although this response was
much larger in endothelial-activated versus astrocyte-
activated microglia (Fig. 2b). CD86 was upregulated in
endothelial-activated microglia, whereas CD206 was upreg-
ulated in astrocyte-activated microglia (Fig. 2b). No effects
of endo-CM or astro-CM were observed for microglial
expression of Arg1 (Fig. 2b).
Finally, we asked whether endothelium and astrocytes
may also affect microglial function. Endo-CM treatment
inhibited microglial migration (Fig. 3a) and phagocytosis
(Fig. 3b), whereas astro-CM treatment enhanced micro-
glial phagocytosis (Fig. 3b).
Different effects of endothelial-activated versus
astrocyte-activated microglia on neurons
Our findings indicated that endothelial cells and astrocytes
might activate microglia into different phenotypes. Here, we
performed two-step media transfer experiments to test
whether these differentially activated microglia were toxic or
beneficial towards neurons. First, rat cerebral endothelial
cells or astrocytes were subjected to similar protocols of 4 h
OGD and 24 h reoxygenation; then, their conditioned media
were collected and added to microglia. After 24 h of culture
in either endo-CM or astro-CM, a second media transfer
was performed, i.e., microglial-conditioned media were col-
lected and transferred onto the primary rat cortical neurons.
Neuronal cell viability assays showed that conditioned
media from endothelial-activated microglia were moderately
neurotoxic (p= 0.0272, one-way ANOVA) (Fig. 4a). In
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Fig. 1 Different effects of oxygen-glucose-deprived endothelium versus astrocytes on microglial activation. a Morphology of primary microglia
without or with 24 h of treatment with conditioned media from the OGD-treated cerebral endothelial cells or astrocytes. Untreated “resting”
microglia displayed a ramified morphology (left). Endo-CM treatment activated microglia into an amoeboid appearance (middle). Astro-CM treatment
led to microglial cell body enlargement and reduced peripheral branching (right). b Secretion of TNFα, IL-1β, IL-10, and IGF-1 from the
primary microglia treated with conditioned media from OGD-treated cerebral endothelial cells or astrocytes for 24 h were measured using
ELISA. Endothelial-activated microglia significantly increased the production of TNFα, IL-1β, and IL-10 and reduced IGF-I release. In contrast,
astrocyte-activated microglia did not alter the levels of TNFα, IL-1β, and IL-10 but significantly increased the IGF-1 release. Data were
expressed as mean ± SD. **p < 0.01 compared to the control (one-way ANOVA). n = 3 to 5 independent experiments
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contrast, conditioned media from astrocyte-activated micro-
glia did not affect neuronal viability (Fig. 4a).
To assess potential benefit, we next measured the effects
of these activated microglia on surrogate markers of neu-
roplasticity. Once again, a two-step media transfer experi-
ment was performed. The rat cerebral endothelial cells or
astrocytes were subjected to 4 h OGD and 24 h reoxygen-
ation, and then their conditioned media were collected
and added to microglia. After 24 h of culture in either
endo-CM or astro-CM, a second media transfer was per-
formed, i.e., microglial-conditioned media were collected
and transferred onto the primary rat hippocampal
neurons previously labeled with green fluorescent pro-
tein (Fig. 4b). After 5 days, dendritic morphology was
quantified. Endothelial-activated microglia did not ap-
pear to alter neuronal dendrites. However, astrocyte-
activated microglia significantly increased dendritic
complexity (Fig. 4b, c).
Potential roles of transcription factors in microglial
phenotypic switching
To explore the potential roles of transcription factors in
microglia phenotypic switch, we detected several members
of interferon-regulatory factor (IRF) protein family and
the signal transducer and activator of transcription
(STAT) protein family using real-time PCR, including
IRF4, 5, 7, 8, and 9 and STAT1, 3, and 6. The microglia
were incubated with the conditioned media from OGD-
treated endothelial cells or astrocytes for 4 h. Endo-CM
treatment significantly downregulated IRF4 expression
and upregulated IRF7 expression in microglia, but astro-
CM treatment did not significantly change the expression
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Fig. 2 Oxygen-glucose-deprived endothelium and astrocyte activated microglia into different phenotypes. a Cell surface markers of microglia
were detected by flow cytometry. Expression levels of CD45, CD86, and MHC II were significantly elevated in endo-CM-treated microglia. In
contrast, no changes in these cell surface markers were detected in astro-CM-treated microglia. Data were expressed as mean ± SD. *p < 0.05 and
**p < 0.01 compared to the control (one-way ANOVA). n = 3 independent experiments. b Microglial activation markers (iNOS, CD86, CD206, and
arginase 1) were measured with real-time PCR. Endo-CM significantly increased microglial expression of iNOS. CD86 was upregulated in
endothelial-activated microglia, whereas CD206 was upregulated in astrocyte-activated microglia. Data were expressed as mean ± SEM. n = 3
independent experiments
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levels of IRFs and STATs (Fig. 5a). In addition, endo-CM
treatment significantly raised the ratio of IRF5/IRF4 in
microglia compared with astro-CM treatment (Fig. 5b).
Discussion
Injury or disease will trigger complex cascades of multi-
cellular and multi-factorial pathways in the CNS. It is now
recognized that these endogenous mechanisms comprise a
mix of potentially deleterious and potentially beneficial re-
sponses. After stroke or brain injury, initial pathways of
secondary damage in the acute phase may eventually yield
to endogenous attempts at tissue remodeling during the
recovery phase [35]. In neurodegeneration, the onset of a
disease is initially counterbalanced by repair mechanisms
of neuroplasticity and adaptation, but eventually, accumu-
lating deficits overcome the ability to compensate [36].
Many cells will surely be involved, but the dynamic balance
between good and bad can perhaps be best reflected in the
complex spectrum of microglia activation. All these differ-
ing aspects of microglial function are typically swept under
a general rubric of activation. But how are different states
of microglial activation initially triggered? Our current
study suggests that crosstalk with other cells in the neuro-
vascular unit may play a potential role. Conditioned media
from OGD-injured cerebral endothelial cells activated
microglia and caused them to release large amounts of
TNFα and IL-1β; upregulated CD45, CD86, MHCII, and
iNOS; and inhibited microglial migration and phagocytosis.
In contrast, microglia that were activated by conditioned
media from OGD-injured astrocytes showed increased
production of IGF-1, upregulated CD206, and enhanced
phagocytosis. These different states of microglial activation
may also have neuronal consequences. Endothelial-
activated microglia were moderately neurotoxic, whereas
astrocyte-activated microglia promoted neuronal dendritic
plasticity. Taken together, our present findings may allow
one to hypothesize a gliovascular mechanism for regulating
the microglial switch (Fig. 6).
Although the present study is based on cell biology
model systems, these findings may allow one to propose a
new hypothesis with in vivo implications, especially for
stroke. Under normal conditions, microglia reside behind
the blood-brain barrier. During the acute phase of stroke,
the loss of blood-brain barrier (BBB) integrity [37] allows
microglia to now “see” the endothelium, resulting in the
first state of activation that may be potentially damaging.
Thereafter, during stroke recovery, the BBB is re-sealed and
astrogliosis begins to take place [38], and now, exposure to
reactive astrocytes may switch the microglia into the sec-
ond state of activation that could be potentially beneficial.
Preliminary results may support this hypothesis. Microglia
isolated from the ischemic rodent brains showed distinct
waves of gene expression (Additional file 3: Figure S3). At
3 days after transient focal ischemia, microglia expressed
high levels of TNFα and IL-1β, similar to our endothelial-
activated microglial cultures. By 14 days post-ischemia,
TNFα and IL-1β levels tended to come back down, whereas
the expression of IGF-1 were increased, similar to our
astrocyte-activated microglial cultures. Of interest, this bi-
phasic pattern of microglial activation after focal cerebral is-
chemia seemed to approximately match the well-known
timing of BBB breakdown followed by proliferation of re-
active astrocytes (Additional file 4: Figure S4).
Microglial activation in the CNS will be complex, and
its phenotype may not be cleanly divided into either clas-
sically activated “M1-like” states or alternatively activated
“M2-like” states. Instead, an entire spectrum of pheno-
types may exist that span the range from deleterious to
regulatory to remodeling effects [39–42]. Whether certain
microglial phenotypes are beneficial or detrimental
depends on the situation. Any insult could activate
microglia, and the primary purpose of microglial activa-
tion is to help. Microglial migration and phagocytosis may
be good for the removal of infective pathogens and dead
neurons after injury. However, overactivated microglia
may further damage neurons. Our study supported this
idea. Endothelium-activated microglia had typical
amoeboid morphology, but they had a reduced ability to
phagocytose. Microglia activated by endothelium not only
released a large amount of pro-inflammatory factors, such
as TNFα and IL-1β, but also increased the release of anti-
inflammatory IL-10 at the same time. Astrocyte-activated
microglia showed enhanced phagocytosis with non-
amoeboid shape and upregulated the “M2-like” marker
CD206, but also slightly increased the “M1-like” marker
iNOS. Hence, a simple “M1-like” versus “M2-like” classifi-
cation may not be appropriate for microglial phenotyping
after stroke. However, if we consider the classification of
microglial phenotype according to their functions, our
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Fig. 3 Altered microglia functions after treatment with conditioned
media from endothelial cells or astrocytes. a Migration. b Phagocytosis.
Endo-CM treatment inhibited microglial migration and phagocytosis,
whereas astro-CM treatment enhanced microglial phagocytosis. Data
were expressed as mean ± SD. *p < 0.05 and **p < 0.01 compared to
the control; ##p< 0.01 compared to astro-CM-treated microglia (one-way
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findings may suggest that endothelial cells somehow
activated microglia into a potentially damaging pheno-
type—toxic to neurons. In contrast, astrocytes somehow
induced a different activation state in microglia—promot-
ing neuroplasticity.
Different transcription factors may play key roles in
microglial regulation, including members of the IRF and
STAT families [23]. A preliminary assessment in our
model system suggests that neither endothelium nor
astrocytes altered STAT1, STAT3, or STAT6, but signifi-
cant changes were noted for the IRF family. Endothelial-
activated microglia downregulated IRF4 and IRF5 but
upregulated IRF7. In astrocyte-activated microglia, IRF4,
IRF5, and IRF7 were all uniformly downregulated. IRFs
comprise a group of transcription factors that are related
to the regulation of gene expression in the immune
response. IRF4 is a negative regulator of inflammation
and mediates M2 polarization of macrophages [43–45].
IRF5 induces the expression of pro-inflammatory factors
and promotes the M1 polarization of macrophages [46,
47]. More recently, it has been proposed that the balance
between IRF5 and IRF4 influences microglial activity
and corresponds to infarct size and neurological deficits
[48, 49]. In our model system, IRF5/IRF4 ratios were sig-
nificantly higher in endothelial-activated microglia com-
pared to astrocyte-activated microglia, consistent with
potentially deleterious properties of the former versus
the latter. The role of IRF7 in microglial polarization
may be controversial. One study showed that IRF7 ex-
pression increased during M2-like to M1-like conver-
sions in microglia, and knockdown of IRF7 suppressed
the expression of M1-like markers induced by LPS [50].
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Fig. 4 Different effects of endothelial-activated versus astrocyte-activated microglia on the neurons. a MTT assays of neuronal cell viability. Conditioned
media from endothelial-activated microglia were moderately neurotoxic. In contrast, conditioned media from astrocyte-activated microglia did not affect
neuronal viability. p= 0.0272 (one-way ANOVA). b Representative hippocampal neurons transfected with pEGFP-C1 vector. c Graph of dendritogenesis.
Astrocyte-activated microglia significantly increased dendritic complexity. Data were expressed as mean ± SD. *p< 0.05 compared to the control (one-way
ANOVA). n= 21 to 23 individual neurons
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Fig. 6 Summary schematic of gliovascular regulation of the microglial switching from injury into repair within the neurovascular unit. The first
phase of deleterious microglia matches the loss of BBB integrity during acute injury. The second phase of beneficial microglia matches
the appearance of reactive astrocytes during delayed recovery
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Fig. 5 Potential roles of transcription factors in microglial phenotypic switching. a Expression of IRFs and STATs were detected by real-time PCR. Endo-CM
treatment significantly downregulated IRF4 expression and upregulated IRF7 expression in microglia, but astro-CM treatment did not significantly change
the expression levels of IRFs and STATs. Data were expressed as mean ± SD. *p< 0.05 compared to the control (t test). n= 3 independent experiments. b
Bar graph of the ratio of IRF5/IRF4. Endo-CM treatment significantly raised the ratio of IRF5/IRF4 in microglia compared with astro-CM treatment. Data were
expressed as mean ± SD. *p< 0.05 (t test). n= 3 independent experiments
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Another study found that the decrease of IRF7 kept
microglia in M1-like polarization and upregulation of
IRF7 switched microglia to M2-like phenotype [51]. In
our study, exposure to OGD-injured endothelial media
upregulated IRF7 in recipient microglia, suggesting that
IRF7 may be related to an initially damaging phenotype.
Gain- and loss-of-function experiments will be required
to carefully define the role of IRFs in the gliovascular
switch for microglia.
Taken together, our findings suggest that differential
signaling from injured endothelium versus astrocytes may
underlie a potential gliovascular mechanism for microglial
regulation and polarization. However, regardless of any cell-
autonomous crosstalk, microglia can possibly respond to
OGD by itself and be activated without other cell stimula-
tion. To clarify this issue, we included two more experi-
ments. At first, we detected gene expression and cytokine
release in OGD-treated microglia (Additional file 5: Figure
S5). mRNA levels of iNOS, CD86, CD206, and arginase 1
did not show significant changes in microglia subjected to
OGD for 4 h and reoxygenation for 4 h. In addition, com-
pared with normoxic microglia, OGD did not significantly
change the microglial release of IGF-1, IL-10, IL-1β, and
TNFα. So OGD alone may not significantly affect the char-
acteristics and phenotypes of microglia. Next, we detected
gene expression and cytokine release of endo-CM- or
astro-CM-treated microglia that were previously subjected
to OGD for 4 h before media transfer (Additional file 6:
Figure S6). The expression of iNOS, CD206, and arginase 1
in OGD-treated microglia showed similar changes as nor-
moxic microglia, although there were slight differences in
CD86 in OGD-treated microglia. However, the changes of
TNFα and IL-10 release from OGD-treated microglia were
similar as normoxic microglia. Overall, although there were
slight differences, it seemed that the responses of OGD-
treated microglia to endo-CM or astro-CM might be simi-
lar to normoxic microglia in most aspects, suggesting that
endothelial and astrocytic crosstalk may still be relevant in
the context of overall tissue OGD.
There are several caveats for the present study. First, our
data suggested that endothelium and astrocyte might play
different roles in microglia phenotypic polarization after is-
chemic stroke. However, we do not know the factors in
endothelial versus astrocyte secretomes that are responsible
for differential signaling. It is likely that combinations of
factors will be involved. We will further explore the compo-
nents inside the conditioned media that may be responsible
for differential microglial activation in future studies. Sec-
ond, our experiments are based on media transfer, so sig-
naling is restricted to released and diffusible mediators.
However, within an intact neurovascular unit, direct cell-
cell and cell-matrix interactions should also play a role.
Third, we only measured selected cytokines and genes that
were known to play a role in microglial regulation. A full
construction of the microglial transcriptome under differ-
ent activation states will be eventually required. Fourth, we
used the RBE4 cell line in our present study instead of pri-
mary cultured endothelial cells. RBE4 cells are a commonly
used immortalized rat brain microvessel endothelial cell
line that is very commonly used to study neurovascular
physiology as well as BBB function in vitro [52]. RBE4 cells
exhibit a non-transformed phenotype, possess reproducible
sets of endothelial cell markers, and express BBB-specific
properties [52]. Compared with RBE4 cells, primary culture
of brain endothelial cells is time-consuming and expensive
and is difficult to eliminate all non-endothelial cell contami-
nants. In addition, primary cultured endothelial cells rapidly
de-differentiate in vitro and lose the characteristics of BBB
endothelial cells after a few passages in culture [52]. The
present study used RBE4 cells in order to establish proof of
concept for our new hypothesis. Further studies should
consider using primary endothelial cells for repeating key
experiments. Fifth, immune response after ischemia in the
brain is complicated. Besides the activation of resident im-
mune cell microglia, the infiltration of leukocytes into the
brain parenchyma following ischemic stroke is well-
established, and the infiltrated immune cells comprise both
innate (e.g., neutrophils, macrophages) and subsequently
adaptive (e.g., T and B cells) immune systems [53]. The
interaction between the infiltrated peripheral immune cells
and macrophages may affect the status of microglial pheno-
types and should be considered carefully in future studies.
Conclusions
This proof of concept study may allow one to hypothesize
a differential endothelial versus astrocyte mechanism for
activating microglia. In vivo studies are warranted to rigor-
ously assess and map this gliovascular switch for microglia
in stroke and other CNS disorders.
Additional files
Additional file 1: Figure S1. Cell viability of endothelial cells and
astrocytes after OGD for 4 h and reoxygenation for 24 h. (PDF 56 kb)
Additional file 2: Figure S2. Levels of TNFα, IL-1β, IL-10, and IGF-1 in
culture media from OGD-treated endothelial cells (Endo) or astrocytes
(Astro) were measured using ELISA. (PDF 94 kb)
Additional file 3: Figure S3. Gene expression of microglia sorted from
the ischemic brains by FACS was detected using real-time PCR at differ-
ent time points after ischemia. (PDF 75 kb)
Additional file 4: Figure S4. (a) IgG immunostaining of the brain
sections of rat transient MCAo models at 1, 3, and 7 days after ischemia.
Data were expressed as mean ± SEM. *p < 0.05 (one-way ANOVA). (b)
GFAP immunostaining of the brain sections of rat transient MCAo models
at 1, 3, and 7 days after ischemia. (PDF 3094 kb)
Additional file 5: Figure S5. Gene expression and cytokine release from
OGD-treated microglia. Microglia were subjected to OGD for 4 h and
reoxygenation for 4 h (for gene expression detection using real-time PCR)
or 24 h (for cytokine release detection using ELISA). (a) The levels of iNOS,
CD86, CD206, and arginase1 did not significantly change in microglia
after OGD treatment. (b) Compared with normoxic microglia, OGD
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treatment did not significantly change the release of IGF-1, IL-10,
IL-1β, and TNFα from microglia. (PDF 74 kb)
Additional file 6: Figure S6. Microglia were subjected to OGD for 4 h,
and then endo-CM or astro-CM were added into OGD-treated microglia
for another 8 h (for gene expression experiment using real-time PCR) or
24 h (for ELISA measurement of cytokines). (a) Endo-CM treatment
upregulated the expression of iNOS, whereas astro-CM treatment
upregulated the expression of CD206. (b, c) Endo-CM significantly
increased the release of TNFα and IL-10 from OGD-treated microglia.
(PDF 104 kb)
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